Peptide therapy is not a walk-up wellness product you can simply buy off a menu. It is prescription medical care that requires a consultation, a good faith medical exam, eligibility screening, and an individualized prescription from a licensed physician or nurse practitioner. If a provider offers to sell you peptides without any of these steps, that is a reason to walk away.
At WholeHealth Hydration, the consultation exists to answer one question honestly: is this appropriate and safe for you specifically. Some people are strong candidates. Some are not. The purpose of the visit is to find out, using your history, your exam, and your labs, rather than to sell you something.
This page explains what happens at each step so you can arrive prepared. It is educational information, not medical advice. Always consult your physician about your own situation. In a medical emergency, call 911.
Step one: the initial consultation and good faith medical exam
Your visit begins with a conversation and a good faith medical exam performed by a licensed provider. A good faith exam means the prescriber genuinely evaluates you, in person or through a compliant telehealth encounter, before anything is considered. It is the legal and ethical foundation of responsible prescribing, and it is non-negotiable.
During this exam the provider assesses your general health, discusses your goals, and begins to understand whether a peptide protocol could reasonably fit your situation. This is also your time to ask questions and to raise any concerns.
Expect an honest, unhurried conversation. The provider may tell you that peptides are not the right path for you, or that other steps should come first. That candor is a feature of good care, not a sales tactic.
- Bring a current list of medications, supplements, and known allergies
- Note any past surgeries, chronic conditions, or family medical history
- Come with your goals and your questions written down
Step two: health history and lab review
A thorough health history is central to the visit. Your provider will ask about existing conditions, prior and current medications, allergies, family history, lifestyle, and what you are hoping to achieve. Small details matter here, because they can change what is safe and appropriate for you.
Depending on your goals and history, the provider may review recent labs or order baseline bloodwork before making any decision. Lab review helps establish a starting picture of your health and flags anything that needs attention before a protocol is considered. It also gives you a baseline to monitor against over time.
Nothing is prescribed on assumptions. The history and lab review exist so that any recommendation is grounded in your actual health data, not a generic template.
Step three: how candidacy is determined and a protocol is built
After the exam, history, and labs, the physician determines whether you are a candidate. Candidacy is an individualized medical judgment. It weighs your goals against your health status, your contraindications, and the current evidence for any peptide being considered.
If you are a candidate, the provider builds a protocol tailored to you rather than handing you a one size fits all package. An individualized protocol accounts for what you are trying to support, your tolerance and history, and how you will be monitored going forward. Ongoing physician oversight is part of responsible peptide care, not an optional add on.
Throughout, the framing stays honest. Peptides are studied to support or researched for various aspects of wellness, and some may support specific goals, but no ethical provider promises a guaranteed outcome or a specific number. Results vary by individual.
- Your goals measured against your medical history and risk factors
- Any contraindications that would make therapy unsafe
- A monitoring plan with follow up and, where appropriate, repeat labs
An honest look at regulatory status
Being clear about regulatory status is part of informed consent, so here it is plainly. The GLP-1 class, which includes semaglutide and tirzepatide, is FDA approved for chronic weight management in eligible adults as an adjunct to a reduced calorie diet and increased physical activity. These are prescription medications with their own screening requirements and monitoring.
Many other peptides are different. Substances such as BPC-157, TB-500, Epitalon, Semax, Selank, and GHK-Cu are investigational and are not FDA approved. Some are prepared by compounding pharmacies and used under physician supervision. As of mid-2026, BPC-157 is not on the FDA's approved list of bulk substances for pharmacy compounding, and whether it should be remains under FDA review. Your physician will explain the current status of anything considered for you.
A trustworthy provider will never imply FDA approval where none exists. If a peptide is investigational, you deserve to hear that clearly so you can make an informed choice together with your physician.
Who is not a good candidate
Honesty here protects you. Peptide therapy is not appropriate for everyone, and part of the consultation is identifying when it should not proceed. Your provider makes this determination individually, but some situations commonly warrant caution or exclusion.
For GLP-1 medications specifically, key contraindications include a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and they are not used during pregnancy. A history of pancreatitis, gallbladder disease, or significant gastrointestinal conditions is evaluated carefully before any decision. Common side effects such as nausea and other gastrointestinal upset are discussed openly, and GLP-1 therapy is intended as an adjunct to diet and exercise with ongoing physician monitoring.
More broadly, people who are pregnant or breastfeeding, who have certain active medical conditions, or whose history raises safety concerns may be advised against therapy. If that is you, a good provider will tell you directly rather than proceed anyway.
- Personal or family history of medullary thyroid carcinoma or MEN2 (GLP-1)
- History of pancreatitis or gallbladder disease, evaluated case by case
- Pregnancy or breastfeeding
- Active conditions or a history that make therapy unsafe for you
Questions worth asking at your consultation
A good consultation invites your questions. Coming prepared helps you evaluate whether a provider is practicing responsibly and helps you make a genuinely informed decision.
The right provider will welcome each of these and answer without pressure. If any question is brushed aside, treat that as useful information about the quality of care on offer.
- Is this peptide FDA approved, or is it investigational or compounded and used under physician supervision
- Who is the licensed prescriber, and how will I be monitored over time
- What are the realistic expectations, and what are the known risks and side effects
- What contraindications apply to me based on my history and labs
- What follow up and repeat testing will my protocol include
Frequently asked questions
Do I need a consultation before starting peptide therapy?
Yes. Peptide therapy is physician-guided medical care. It requires a consultation, a good faith medical exam, eligibility screening, and an individualized prescription from a licensed physician or nurse practitioner. Nothing is prescribed without a medical evaluation. This is not a product you can simply buy.
Are peptides FDA approved?
It depends on the peptide. The GLP-1 class, including semaglutide and tirzepatide, is FDA approved for chronic weight management in eligible adults. Many other peptides, such as BPC-157, TB-500, Epitalon, Semax, Selank, and GHK-Cu, are investigational and not FDA approved. Some are compounded and used under physician supervision. Your provider will tell you the status of anything being considered.
What happens during the good faith medical exam?
A licensed provider evaluates your general health, reviews your history, medications, and allergies, discusses your goals, and may review or order labs. The good faith exam is the required foundation of responsible prescribing and must happen before any protocol is considered. This is educational information, not medical advice. Consult your physician about your situation.
Can you tell me how much weight I will lose on a GLP-1 medication?
No responsible provider promises a specific number. For example, in the STEP 1 trial, participants taking semaglutide 2.4 mg lost on average about 14.9 percent of body weight over 68 weeks alongside lifestyle changes, but results vary by individual. GLP-1 therapy is an adjunct to diet and exercise with ongoing physician monitoring, and any expectations are set individually during your consultation.
Who should not consider peptide therapy?
Candidacy is determined individually by your provider. For GLP-1 medications, contraindications include a personal or family history of medullary thyroid carcinoma or MEN2, and they are not used in pregnancy. A history of pancreatitis or gallbladder disease is evaluated carefully. People who are pregnant or breastfeeding, or who have certain active conditions, may be advised against therapy. In a medical emergency, call 911.
How do I book a peptide consultation?
You can book a medical consultation with WholeHealth Hydration by calling (213) 652-2912. We are based in Chino Hills and serve Orange County, Los Angeles, Riverside, and San Bernardino. The booking is for a physician consultation, not a walk-in drip, and it is the first step toward finding out whether peptide therapy is appropriate for you.